 |
PDBsum entry 4xg8
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4xg8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of an inhibitor-bound syk
|
|
Structure:
|
 |
Tyrosine-protein kinase syk. Chain: a, c. Fragment: protein kinase domain, residues 356-635. Synonym: spleen tyrosine kinase,p72-syk. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: syk. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108.
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.249
|
R-free:
|
0.275
|
|
|
Authors:
|
 |
S.J.Lee,J.Choi,B.G.Han,H.Song,J.S.Koh,B.I.Lee
|
|
Key ref:
|
 |
S.J.Lee
et al.
(2016).
Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs.
Febs J,
283,
3613-3625.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
30-Dec-14
|
Release date:
|
30-Dec-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P43405
(KSYK_HUMAN) -
Tyrosine-protein kinase SYK from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
635 a.a.
258 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Febs J
283:3613-3625
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs.
|
|
S.J.Lee,
J.S.Choi,
B.G.Han,
H.S.Kim,
H.J.Song,
J.Lee,
S.Nam,
S.H.Goh,
J.H.Kim,
J.S.Koh,
B.I.Lee.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |